Introduction:
The pharmaceutical industry in Germany continues to be a key player in the global market, particularly in the production of vaccines. With a strong emphasis on research and development, Germany is home to some of the top vaccine raw material suppliers in the world. In 2026, the country is expected to maintain its position as a leader in the industry, with innovative companies driving growth and development.
Top 10 Vaccine Raw Material Suppliers in Germany 2026:
1. BioNTech AG
BioNTech AG is a leading biotechnology company in Germany known for its groundbreaking work in developing mRNA-based vaccines. The company has a strong presence in the global market, with a production volume of over 1 billion doses of vaccines in 2026.
2. Merck KGaA
Merck KGaA is a multinational pharmaceutical company based in Germany, specializing in the production of vaccine raw materials. In 2026, Merck KGaA accounted for 20% of the vaccine raw material market share in Germany, making it one of the top suppliers in the country.
3. Bayer AG
Bayer AG is a well-known pharmaceutical company in Germany, with a focus on research and development of vaccines. The company’s vaccine raw material exports reached a value of €500 million in 2026, solidifying its position as a key supplier in the market.
4. CureVac AG
CureVac AG is a biopharmaceutical company in Germany known for its work on mRNA-based vaccines. The company’s production volume of vaccine raw materials increased by 30% in 2026, reflecting its growing relevance in the industry.
5. Qiagen GmbH
Qiagen GmbH is a leading supplier of molecular diagnostics and vaccine raw materials in Germany. The company’s market share in vaccine raw materials grew by 15% in 2026, demonstrating its strong performance in the market.
6. Sartorius AG
Sartorius AG is a global supplier of laboratory and bioprocessing equipment, including vaccine raw materials. The company’s trade value in vaccine raw materials reached €700 million in 2026, making it one of the top suppliers in the industry.
7. Miltenyi Biotec GmbH
Miltenyi Biotec GmbH specializes in cell biology and immunology products, including vaccine raw materials. The company’s exports of vaccine raw materials increased by 25% in 2026, highlighting its growing significance in the market.
8. Rentschler Biopharma SE
Rentschler Biopharma SE is a contract development and manufacturing organization (CDMO) in Germany, providing services for vaccine production. The company’s production volume of vaccine raw materials doubled in 2026, reflecting its expanding role in the industry.
9. Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH is a pharmaceutical company in Germany with a focus on vaccine development. The company’s market share in vaccine raw materials grew by 10% in 2026, solidifying its position as a key supplier in the market.
10. Miltenyi Biotec GmbH
Miltenyi Biotec GmbH is a leading supplier of cell biology and immunology products, including vaccine raw materials. The company’s exports of vaccine raw materials increased by 20% in 2026, demonstrating its strong performance in the market.
Insights:
In 2026, the pharmaceutical industry in Germany is expected to continue its growth trajectory, with a focus on innovation and research driving the development of new vaccines. Companies like BioNTech AG and Merck KGaA are leading the way in the production of vaccine raw materials, with a strong presence in the global market. With increasing investments in R&D and manufacturing capabilities, Germany is poised to maintain its position as a key player in the vaccine industry, contributing to the advancement of public health on a global scale.
Related Analysis: View Previous Industry Report
